학술논문
MAP2K1 is a potential therapeutic target in erlotinib resistant head and neck squamous cell carcinoma
Document Type
Article
Author
Source
In: Scientific Reports . (Scientific Reports, 1 December 2019, 9(1))
Subject
Language
English
ISSN
20452322